Abstract
Autism spectrum disorder (ASD) is currently estimated to affect more than 1% of the world population. For people with ASD, gastrointestinal (GI) distress is a commonly reported but a poorly understood co-occurring symptom. Here, we investigate the physiological basis for GI distress in ASD by studying gut function in a zebrafish model of Phelan-McDermid syndrome (PMS), a condition caused by mutations in the
gene.
To generate a zebrafish model of PMS, we used CRISPR/Cas9 to introduce clinically related C-terminal frameshift mutations in
and
zebrafish paralogues (
). Because PMS is caused by
haploinsufficiency, we assessed the digestive tract (DT) structure and function in zebrafish
heterozygotes. Human
mRNA was then used to rescue DT phenotypes in larval zebrafish.
Significantly slower rates of DT peristaltic contractions (
< 0.001) with correspondingly prolonged passage time (
< 0.004) occurred in
mutants. Rescue injections of mRNA encoding the longest human
isoform into
mutants produced larvae with intestinal bulb emptying similar to wild type (WT), but still deficits in posterior intestinal motility. Serotonin-positive enteroendocrine cells (EECs) were significantly reduced in both
and
mutants (
< 0.05) while enteric neuron counts and overall structure of the DT epithelium, including goblet cell number, were unaffected in
larvae.
Our data and rescue experiments support mutations in
as causal for GI transit and motility abnormalities. Reductions in serotonin-positive EECs and serotonin-filled ENS boutons suggest an endocrine/neural component to this dysmotility. This is the first study to date demonstrating DT dysmotility in a zebrafish single gene mutant model of ASD.
